MOSAIC research

We’re excited to announce that Gustave Roussy is the third hospital to start generating spatial omics data from patients in the MOSAIC study. Gustave Roussy follows CHUV | Lausanne university hospital and Universitätsklinikum Erlangen, which started molecular profiling of patients in December 2023. With three leading cancer research hospitals (across three different countries) actively engaged in the data generation phase of the MOSAIC study, we're committed to advancing cancer research through spatial omics and AI 💪 #spatialomics #AI #cancerresearch

Mark your calendars 🗓️ On June 17 at 16:20 CEST, our Principal Research Scientist, Atanas Kamburov, will present on MOSAIC alongside Dr. Stefan Florian from Charité - Universitätsmedizin Berlin at the Current Topics in Bioinformatics Symposium in Berlin. Dr. Florian will introduce the academic-industry collaboration, while Atanas will discuss some of the exciting initial results generated by the Owkin team from MOSAIC. Register now https://lnkd.in/eCJiVHBC

#ASCO24 Day 1: Vassili Soumelis, Owkin’s Chief Medical Officer, talks about how the convergence of #spatialomics and #AI will spark the next revolution in cancer research. Come to the Owkin booth (#30095) to learn more about MOSAIC — explore how we are building an unprecedented spatial atlas of cancer cells with 7,000 patient samples, and how that is reshaping our understanding of the tumor microenvironment and opening doors to groundbreaking discoveries and treatments. Book a meeting with us at https://lnkd.in/eCemTe_Q

Come visit us at the Owkin booth #30095 at #ASCO24 in Chicago on June 1-3 to learn more about MOSAIC and how we’re on track to build the world's largest spatial and multiomics dataset in oncology. We already have 7,000 samples from 700+ patients in the study, covering 5 cancer indications and 6 data modalities. Book a meeting with our team https://lnkd.in/eCemTe_Q or visit the stand to meet our scientists and technical experts to talk about the early results from the project #spatialomics #AI #cancerresearch

MOSAIC is pioneering large-scale spatial omics with world-leading academic and industry partners as we build the world's largest oncology dataset with multimodal data from 7,000 patients. We have now included 600 patients, covering 5 cancer indications and 6 data modalities, with our partnering cancer research hospitals across Europe and the US - Gustave Roussy CHUV | Lausanne university hospital, Universitätsklinikum Erlangen, chariteberlin and University of Pittsburgh. Follow the MOSAIC journey as we explore the cross-over between spatial omics and AI to understand complex biology and ensure every patient gets the right treatment. Learn more at www.mosaic-research.com

We’re excited to announce that Gustave Roussy is the third hospital to start generating spatial omics data from patients in the MOSAIC study. Gustave Roussy follows CHUV | Lausanne university hospital and Universitätsklinikum Erlangen, which started molecular profiling of patients in December 2023. With three leading cancer research hospitals (across three different countries) actively engaged in the data generation phase of the MOSAIC study, we're committed to advancing cancer research through spatial omics and AI 💪 #spatialomics #AI #cancerresearch

We’re excited to announce that the University of Pittsburgh is the fifth hospital to start generating spatial omics data from patients in the MOSAIC study. They follow Gustave Roussy, CHUV | Lausanne university hospital, Universitätsklinikum Erlangen, Charité - Universitätsmedizin Berlin, which started the molecular profiling of patients earlier this year. Alongside these esteemed cancer research hospitals actively engaged in the data generation phase of the MOSAIC study, we're committed to advancing cancer research through spatial omics and AI. 💪 #spatialomics #AI #cancerresearch

Great session on Sunday at #AACR2024 on machine learning and spatial biology, with Owkin’s Chief R&D Officer Jean-Philippe Vert, Raphael Gottardo and Elana Fertig. JP presented some exciting first results from the Owkin-led MOSAIC initiative to generate a multimodal spatial atlas of cancer on thousands of patients. In his talk, JP explored the challenges and opportunities that spatial omics and AI can help us with: 📊 Boost the quality of the data 🔬 Augment 1000x the number of samples 🤖 Capture the complexity of multi-scale biology in data-driven AI foundation models 🧬 Use them to infer causal models of biology to ultimately accelerate drug discovery and development MOSAIC is helping accelerate Owkin’s mission to understand complex biology and ensure every patient gets the right treatment. Read more from GenomeWeb and Precision Medicine Online https://lnkd.in/d99ZXnaq #AI #spatialomics #machinelearning

Yesterday, we held our first Spatial Omics Workshop at our office in Paris, with talks from spatial biology experts Raphael Gottardo (CHUV | Lausanne university hospital) and Gunnar Rätsch (ETH AI Center). The meeting was also a great opportunity to discuss data analysis challenges and opportunities linked to spatial omics with some of our MOSAIC research partners. The key takeaways from the event are: 🧑💻 The integration of multiple modalities including spatial omics, and their application in biomedical research, is a key challenge and a very active field of research. 💪 The technological challenges that come with the data generation and analysis for such a novel modality are unique, especially at the unprecedented scale we are working with in the context of MOSAIC. 🧬 AI applications are quickly maturing in #spatialomics, allowing researchers to discover new biology. New approaches are introduced at a very fast pace and are needed to fully leverage the unprecedented richness of this modality. Follow us on www.mosaic-research.com to find out more about how, together with some of the best research centers in Europe for spatial research, we are taking a leading role by building the world‘s largest spatial omics dataset in oncology.

Our Senior Computational Biologist Christian Bromley introduces the MOSAIC project at the Spatial Biology UK 2024 conference in London. 🇬🇧 Coming back from the conference, here are Christian’s key takeaways: 💻 Technological advancements in the field are happening fast. 🧬 Those technologies that are able to combine single-cell and even nanoscale resolution with high throughput detection of mRNA and protein will fuel AI-driven discoveries. 🌎 Most researchers are doing very small-scale experimentation, and do not have the funding and AI expertise to truly harness the potential of these technologies. MOSAIC is our response to the need for large-scale datasets to drive clinically relevant discoveries from spatial omics data through the lens of AI. Learn more at https://lnkd.in/eJBqQ6Rw #spatialomics #AI